Unibest

Pharmaceutical intermediates

Beraprost Sodium Intermediates

1 pharmaceutical intermediate for Beraprost Sodium. Indication: Pulmonary hypertension; Peripheral vascular disease.

Submit a ProjectAll intermediates

About Beraprost Sodium

Originator
Toray Industries, Inc.
Indication
Pulmonary hypertension; Peripheral vascular disease
Approved Date
12/17/1999

Available intermediates

1 intermediate currently listed for Beraprost Sodium. Request specifications, documentation or a quotation for any item below.

Beraprost Sodium intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(1R,3R)-Cyclopent-4-ene-1,3-diol Monoacetate60410-17-5//

Other programs under B

Baloxavir MarboxilBaricitinibBDTX-1535Bedaquiline FumarateBelumosudil mesylateBelzutifanBempedoic acidBictegravir

Building toward Beraprost Sodium?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →